These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16018598)

  • 61. [mFOLFIRINOX for adjuvant therapy of pancreatic cancer].
    Strobel O; Büchler MW
    Chirurg; 2019 Mar; 90(Suppl 2):59. PubMed ID: 30758631
    [No Abstract]   [Full Text] [Related]  

  • 62. [mFOLFIRINOX for adjuvant therapy of pancreatic cancer].
    Strobel O; Büchler MW
    Chirurg; 2018 Dec; 89(12):1007. PubMed ID: 30357431
    [No Abstract]   [Full Text] [Related]  

  • 63. Treatment and Survival of Elderly Patients with Stage I-II Pancreatic Cancer: A Report of the EURECCA Pancreas Consortium.
    Groen JV; Douwes TA; van Eycken E; van der Geest LGM; Johannesen TB; Besselink MG; Koerkamp BG; Wilmink JW; Bonsing BA; Portielje JEA; van de Velde CJH; Bastiaannet E; Mieog JSD;
    Ann Surg Oncol; 2020 Dec; 27(13):5337-5346. PubMed ID: 32388741
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Surgical oncology for pancreatic cancer; future perspective].
    Unno M
    Nihon Shokakibyo Gakkai Zasshi; 2015 Dec; 112(12):2113-8. PubMed ID: 26638782
    [No Abstract]   [Full Text] [Related]  

  • 65. Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer.
    Mukherjee I; Powell B; Parianos M; Downs D; Ross SB
    Cancer Genet; 2016 Dec; 209(12):582-591. PubMed ID: 27613576
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ASO Author Reflections: Postoperative Chemotherapy After Neoadjuvant Therapy and Pancreatectomy for Pancreatic Cancer: Balancing Patient Physiology and Disease Biology.
    Kamarajah SK; Dahdaleh F
    Ann Surg Oncol; 2021 Oct; 28(11):6803-6804. PubMed ID: 33774772
    [No Abstract]   [Full Text] [Related]  

  • 67. Goals of Treatment Sequencing for Localized Pancreatic Cancer.
    Evans DB; Kamgar M; Tsai S
    Ann Surg Oncol; 2019 Nov; 26(12):3815-3819. PubMed ID: 31493126
    [No Abstract]   [Full Text] [Related]  

  • 68. Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal".
    Ghaneh P; Tudur-Smith C; Neoptolemos JP
    Drugs; 2007; 67(17):2487-90; discussion 2491-3. PubMed ID: 18034586
    [No Abstract]   [Full Text] [Related]  

  • 69. [Neoadjuvant chemotherapy for pancreatic carcinoma].
    Motoi F; Rikiyama T; Katayose Y; Egawa S; Unno M
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1654-60. PubMed ID: 21971140
    [No Abstract]   [Full Text] [Related]  

  • 70. Access to radical resections of pancreatic cancer is region-dependent despite the public healthcare system in Finland.
    Ahola R; Hölsä H; Kiskola S; Ojala P; Pirttilä A; Sand J; Laukkarinen J
    J Epidemiol Community Health; 2018 Sep; 72(9):803-808. PubMed ID: 29720389
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Current State of Vascular Resections in Pancreatic Cancer Surgery.
    Hackert T; Schneider L; Büchler MW
    Gastroenterol Res Pract; 2015; 2015():120207. PubMed ID: 26609306
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pancreatic carcinoma.
    Klamer TW; Max MH
    South Med J; 1982 Jul; 75(7):780-2. PubMed ID: 7089642
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surgeon-Led Clinical Trials in Pancreatic Cancer.
    Chawla A; Ferrone CR
    Surg Oncol Clin N Am; 2023 Jan; 32(1):143-151. PubMed ID: 36410914
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Curing pancreatic cancer.
    Traub B; Link KH; Kornmann M
    Semin Cancer Biol; 2021 Nov; 76():232-246. PubMed ID: 34062264
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Pancreatic tumor: progress in diagnosis and treatment. Topics: I. Pancreatic carcinoma; 4. Progress of non-surgical treatment for pancreatic cancer].
    Ueno H; Okusaka T
    Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):29-36. PubMed ID: 22413458
    [No Abstract]   [Full Text] [Related]  

  • 76. ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer.
    Andrianello S; Marchegiani G; Salvia R
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):810-811. PubMed ID: 30374921
    [No Abstract]   [Full Text] [Related]  

  • 77. Managing inoperable pancreatic cancer: the role of the pancreaticobiliary physician.
    Yau CC; Leeds J
    Frontline Gastroenterol; 2022; 13(e1):e88-e93. PubMed ID: 35812020
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neoadjuvant Treatment and Surgical Resection Are Associated with Survival in Pancreatic Cancer.
    He J; Schmocker R
    J Am Coll Surg; 2021 Jun; 232(6):1023-1024. PubMed ID: 33722461
    [No Abstract]   [Full Text] [Related]  

  • 79. Pancreatic cancer: are more chemotherapy and surgery needed?
    Deplanque G; Demartines N
    Lancet; 2017 Mar; 389(10073):985-986. PubMed ID: 28129986
    [No Abstract]   [Full Text] [Related]  

  • 80. Neoadjuvant Chemotherapy in Pancreatic Cancer.
    Jain A; Yip D; Gananadha S
    JAMA Surg; 2021 Apr; 156(4):396-397. PubMed ID: 33439223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.